دورية أكاديمية

Prevalence of Microvascular and Macrovascular Disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study Cohort

التفاصيل البيبلوغرافية
العنوان: Prevalence of Microvascular and Macrovascular Disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study Cohort
المؤلفون: Mather, Kieren J., Bebu, Ionut, Baker, Chelsea, Cohen, Robert M., Crandall, Jill P., DeSouza, Cyrus, Green, Jennifer B., Kirkman, M. Sue, Krause-Steinrauf, Heidi, Larkin, Mary, Pettus, Jeremy, Seaquist, Elizabeth R., Soliman, Elsayed Z., Schroeder, Emily B., Wexler, Deborah J., Pop-Busui, Rodica
المساهمون: Medicine, School of Medicine
المصدر: PMC
بيانات النشر: Elsevier
سنة النشر: 2020
المجموعة: Indiana University - Purdue University Indianapolis: IUPUI Scholar Works
مصطلحات موضوعية: Diabetes, Complications, Prevalence, Treatment, Comparative effectiveness, Pragmatic
الوصف: Aims: The Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) trial is a randomized clinical trial comparing glycemic effects of four diabetes medications added to metformin in type 2 diabetes (T2D). Microvascular and macrovascular diseases are secondary outcomes. We evaluated the prevalence and risk factor relationships for microvascular and macrovascular complications in the GRADE cohort at study entry. Methods: Complication prevalence and risk factors were analyzed based on data from screening in all consenting participants meeting GRADE eligibility. Logistic regression and Z-statistics were used to assess risk factor relationships with complications. Results: We enrolled 5047 T2D participants [mean age 57 years; 36% female; mean known T2D duration 4 years (all < 10 years); mean HbA1c 8.0% (∼64 mmol/mol) at screening]. Urinary albumin/creatinine ratio (ACR) ≥ 30 mg/gram was present in 15.9% participants; peripheral neuropathy (by Michigan Neuropathy Screening Instrument) in 21.5%; cardiovascular autonomic neuropathy by electrocardiography-derived indices in 9.7%; self-reported retinopathy in 1.0%. Myocardial infarction ascertained by self-report or electrocardiogram was present in 7.3%, and self-reported history of stroke in 2.0%. Conclusions: In the GRADE cohort with < 10 years of T2D and a mean HbA1c of 8.0%, diabetes complications were present in a substantial fraction of participants, more so than might otherwise have been expected.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
العلاقة: Diabetes Research and Clinical Practice; Mather KJ, Bebu I, Baker C, et al. Prevalence of microvascular and macrovascular disease in the Glycemia Reduction Approaches in Diabetes - A Comparative Effectiveness (GRADE) Study cohort. Diabetes Res Clin Pract. 2020;165:108235. doi:10.1016/j.diabres.2020.108235; https://hdl.handle.net/1805/31259Test
الإتاحة: https://doi.org/10.1016/j.diabres.2020.108235Test
https://hdl.handle.net/1805/31259Test
حقوق: Publisher Policy
رقم الانضمام: edsbas.F2239330
قاعدة البيانات: BASE